Antibodies that neutralize the hyaluronidase activity of CEMIP have shown utility in the context of experimentally induced arthritis [60], and it would be interesting to see whether a similar approach might have an impact in the context of tumorigenesis and metastasis. This evidence concerns the gene CEMIP and arthritic joint disease.